Targeting VEGF-A to Treat Cancer and Age-Related Macular Degeneration
- 1 February 2007
- journal article
- review article
- Published by Annual Reviews in Annual Review of Medicine
- Vol. 58 (1) , 491-504
- https://doi.org/10.1146/annurev.med.58.061705.145635
Abstract
Inhibiting angiogenesis is a promising strategy to treat cancer and several other disorders, including intraocular neovascular syndromes. The identification of vascular endothelial growth f...Keywords
This publication has 90 references indexed in Scilit:
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- VEGF receptor signalling ? in control of vascular functionNature Reviews Molecular Cell Biology, 2006
- Tumor-Driven Paracrine Platelet-Derived Growth Factor Receptor α Signaling Is a Key Determinant of Stromal Cell Recruitment in a Model of Human Lung CarcinomaClinical Cancer Research, 2006
- Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in miceBlood, 2006
- Angiogenesis in life, disease and medicineNature, 2005
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- The biology of VEGF and its receptorsNature Medicine, 2003
- Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured fab in complex with antigen 1 1Edited by I. A. WilsonJournal of Molecular Biology, 1999
- Failure of blood-island formation and vasculogenesis in Flk-1-deficient miceNature, 1995
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993